Profound Research’s Post

#Didyouknow, sometimes people refer to clinical trials as clinical research. Which is why we might not always be sure of a term or word pertaining to clinical trials. If you have questions or want to learn more about finding a trial for you, our glossary is a great resource to help guide through some basic terms related to clinical trials: bit.ly/CT-Glossary #lupus #lupustrials #lupusresearch

Natural history studies can support approvals of new #raredisease therapies. If you integrate these real-world, protocol-driven studies into the early clinical development planning process, there will be a host of benefits: https://bit.ly/3SB5MIJ #raredisease #clinicaldevelopment

European Joint Clinical Assessments: are you ready? >> https://lnkd.in/exrSE9Rf Is your organization ready for the implementation of European Joint Clinical Assessments of health technologies? Are you keen to understand and navigate the potential impact on your pipeline assets? European Joint Clinical Assessments may present new challenges for your organization, read more...https://lnkd.in/exrSE9Rf #HEOR #Market Access

The cooperation between EMA and EUnetHTA - European Network for Health Technology Assessment is coming to an end, but preparations are continuing for the implementation of the regulation on health technology assessment.   Reviewing achievements over the years at their concluding meeting on 14 September 2023 in Amsterdam, EMA and EUnetHTA 21 highlighted a number of initiatives:   ✅ Completion of 7 joint scientific consultations for medicines ✅ Discussions on evidence needs for ATMP in oncology ✅ Organisation of trainings for patients and healthcare professionals ✅ Recommendation on how to optimise CHMP's medicine assessment reports   Find out more in the news announcement: https://lnkd.in/eCRJCsQD #HTA #EUnetHTA #HealthTechnologyAssessment #AccessibilityOfMedicines

Were you unable to connect with us during ISPOR Europe in November? Discover more about one of the posters showcased by Evidinno by following the link below. Findings highlight a significant social transformation in clinical drug development, emphasizing the role of patients as active collaborators, and suggest that personalized clinical trials hold great promise for enhancing patient recruitment and retention in clinical research. https://lnkd.in/ggVT-t59

Clinical trials are powerful tools for innovation. They test medicines to see how well they work for different patients and answer key research questions needed to deliver new medicines.   Our aspiration at #BMSAustralia is that patients and researchers can experience the impact of scientific advancements and have the support to identify what’s right for them.    Our Study Connect portal is starting point for patients who are considering taking part in our clinical trials. Study Connect is developed to: 📌 Give patients, their caregivers and physicians a place to learn more about clinical trials and how they work 📌 Provide information on the conditions and current trials being conducted by #BMSAustralia 📌 Offer a pre-screen to help identify which clinical trials that a patient might qualify for 📌 Discover stories from people who have participated in clinical trials   Learn more here: https://lnkd.in/gdrGxiz

European Joint Clinical Assessments: are you ready? >> https://lnkd.in/exrSE9Rf Is your organization ready for the implementation of #EuropeanJointClinicalAssessments of health technologies? Are you keen to understand and navigate the potential impact on your pipeline assets? Download our latest case studies and insights >> https://lnkd.in/exrSE9Rf #HEOR #MarketAccess

Even if the study isn’t specifically targeting an underrepresented or minority population, improving diverse participant representation should still be part of the standard plan, right? After all, improved DE&I initiatives in clinical trials = better health outcomes for everyone. 🤝 Increasing underrepresented populations in clinical research is incredibly important for securing diverse data and learning about potential genetic or biological differences and their impact on drug efficacy. We partnered with Acclinate to put together a trend report on DE&I in Clinical Research. Swipe through below to check out some of the key findings or dig into the full report here: https://lnkd.in/gVTY8NkJ How are you building DE&I into your 2024 programs? #DEI #ClinicalResearch #ClinicalTrials